23 November 2017
News and Views
Links and Services
This month's Gastroenterology identifies predictors of improved long-term clinical outcomes in ulcerative colitis with infliximab treatment.
In the Active Ulcerative Colitis Trial (ACT)-1 and ACT-2, patients with ulcerative colitis treate
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors